Colleagues in Japan have led the development of a recent (brief) book on sizing trials with multiple endpoints:
http://link.springer.com/book/10.1007/978-3-319-22005-5
Thank you.
Scott
------Original Message------
Shelley,
This is a common problem in pharma. It depends on whether you define overall success as "at least one" or "both" -- one is a union-intersection test (composite alternative is a union & composite null is intersection) and the other is intersection-union assuming the individual tests are one-sided. The former requires adjustments to maintain the familywise error rate. Either way, this must be done in the protocol stage and not post hoc. There is a nice tutorial in Statistics in Medicine by Dmitrienko and D'Agostino (2013) that discusses several multiple testing procedures for union-intersection tests.
Chris
------------------------------
Christopher Vahl
Assistant Professor of Statistics
Kansas State University
------------------------------
Original Message:
Sent: 09-03-2015 15:24
From: Shelley-Ann Walters
Subject: Two primary endpoints
Hi
I am wondering if anyone has experience in having designed a study with two primary endpoints.
Can you call the study successful if only one endpoint reaches statistical significance and the other does not?
Thanks
Shelley
------------------------------
Shelley-Ann Walters
3M
------------------------------